please find attached herewith Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31.03.2026 alng with Statement of Assess & Liabilities and Annexure I ....
Awaiting price reaction for this filing.
Uniworth International Ltd reported zero revenue from operations for both standalone and consolidated results for FY2026. The company posted a standalone net loss of Rs 157.01 lakhs and consolidated loss of Rs 156.91 lakhs, with EPS of Rs (1.05) per share. The auditor issued a Qualified Opinion due to non-provision of doubtful debts totaling approximately Rs 3,316 lakhs, including overdue export bills of Rs 3,010.57 lakhs, claims receivable of Rs 227.73 lakhs, and other receivables. For consolidated results, auditors were unable to verify the Rs 4.93 lakh investment in newly acquired subsidiary Uniworth Biotech Limited due to denied access to its records. The company disclosed that its business activities have been suspended since long. Total liabilities stand at Rs 16,123.70 lakhs against total assets of Rs 3,342.10 lakhs, indicating severe negative net worth.
The qualified audit opinion and significant doubtful receivables without provisions indicate high credit risk and potential balance sheet impairment. The company's suspended operations and negative net worth raise serious going concern doubts for shareholders. The stock carries high risk given zero operating revenue and auditor concerns about recoverability of major assets.